An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells

This publication has 47 references indexed in Scilit:

• PTEN-deficient cancers depend on PIK3CB
  Proceedings of the National Academy of Sciences, 2008
• The ERBB3 receptor in cancer and cancer gene therapy
  Cancer Gene Therapy, 2008
• Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2008
• MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
  Science, 2007
• Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
  Nature, 2007
• Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines
  The American Journal of Pathology, 2007
• Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy
  Nature Clinical Practice Oncology, 2006
• Effect of Epidermal Growth Factor Receptor Expression Level on Survival in Patients with Epithelial Ovarian Cancer
  Clinical Cancer Research, 2005
• Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation
  Breast Cancer Research and Treatment, 2005
• Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
  Journal of Clinical Immunology, 1991